论文部分内容阅读
The development of new pharmaceutical antibodies is a long and expensive process with sharply increasing costs during clinical trials.Attana Cell 200 is a QCM based biosensor that provides highly informative data about drug candidates in preclinical stage, thus improving selection and reducing the risk of late failures and saves money and time.Attana Cell 200 offers a novel approach to measure label free, full kinetics in real time with the target in its biological context.